101 related articles for article (PubMed ID: 8224612)
1. A potential pathophysiologic role for alpha 2 beta 1 integrin in human eye diseases involving vitreoretinal traction.
Kupper TS; Ferguson TA
FASEB J; 1993 Nov; 7(14):1401-6. PubMed ID: 8224612
[TBL] [Abstract][Full Text] [Related]
2. Collagen gel contraction by cells associated with proliferative vitreoretinopathy.
Guidry C; McFarland RJ; Morris R; Witherspoon CD; Hook M
Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2429-35. PubMed ID: 1634340
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of retinal pigment epithelial cell-induced tractional retinal detachment by disintegrins, a group of Arg-Gly-Asp-containing peptides from viper venom.
Yang CH; Huang TF; Liu KR; Chen MS; Hung PT
Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):843-54. PubMed ID: 8603869
[TBL] [Abstract][Full Text] [Related]
4. Cytokines and serum cause alpha 2 beta 1 integrin-mediated contraction of collagen gels by cultured retinal pigment epithelial cells.
Hunt RC; Pakalnis VA; Choudhury P; Black EP
Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):955-63. PubMed ID: 8125758
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cell-induced vitreous contraction by synthetic peptide derived from the collagen receptor binding sequence.
Yang CH; Huang TF; Liu KR; Chen MS; Hung PT
J Ocul Pharmacol Ther; 1996; 12(3):353-61. PubMed ID: 8875342
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases: a role in the contraction of vitreo-retinal scar tissue.
Sheridan CM; Occleston NL; Hiscott P; Kon CH; Khaw PT; Grierson I
Am J Pathol; 2001 Oct; 159(4):1555-66. PubMed ID: 11583981
[TBL] [Abstract][Full Text] [Related]
7. Proliferative vitreoretinopathy. The mechanism of development of vitreoretinal traction.
Glaser BM; Cardin A; Biscoe B
Ophthalmology; 1987 Apr; 94(4):327-32. PubMed ID: 3587912
[TBL] [Abstract][Full Text] [Related]
8. Collagen gel contraction by ARPE-19 cells is mediated by a FAK-Src dependent pathway.
Morales SA; Mareninov S; Prasad P; Wadehra M; Braun J; Gordon LK
Exp Eye Res; 2007 Dec; 85(6):790-8. PubMed ID: 17915217
[TBL] [Abstract][Full Text] [Related]
9. [Contractile elements in proliferative retinal diseases].
Molitor R; Esser P; Weller M; Wiedemann P; Heimann K
Ophthalmologe; 1992 Feb; 89(1):34-8. PubMed ID: 1581690
[TBL] [Abstract][Full Text] [Related]
10. Immunolocalization of integrins in proliferative retinal membranes.
Robbins SG; Brem RB; Wilson DJ; O'Rourke LM; Robertson JE; Westra I; Planck SR; Rosenbaum JT
Invest Ophthalmol Vis Sci; 1994 Aug; 35(9):3475-85. PubMed ID: 8056523
[TBL] [Abstract][Full Text] [Related]
11. A mechanical model of posterior vitreous detachment and generation of vitreoretinal tractions.
Di Michele F; Tatone A; Romano MR; Repetto R
Biomech Model Mechanobiol; 2020 Dec; 19(6):2627-2641. PubMed ID: 32642790
[TBL] [Abstract][Full Text] [Related]
12. RPE-mediated collagen gel contraction. Inhibition by colchicine and stimulation by TGF-beta.
Raymond MC; Thompson JT
Invest Ophthalmol Vis Sci; 1990 Jun; 31(6):1079-86. PubMed ID: 2354911
[TBL] [Abstract][Full Text] [Related]
13. Proliferative vitreoretinopathy. Ultrastructural study of 20 retroretinal membranes removed by vitreous surgery.
Schwartz D; de la Cruz ZC; Green WR; Michels RG
Retina; 1988; 8(4):275-81. PubMed ID: 3231920
[TBL] [Abstract][Full Text] [Related]
14. Role of the alpha 1 beta 1 integrin complex in collagen gel contraction in vitro by fibroblasts.
Carver W; Molano I; Reaves TA; Borg TK; Terracio L
J Cell Physiol; 1995 Nov; 165(2):425-37. PubMed ID: 7593221
[TBL] [Abstract][Full Text] [Related]
15. Interaction of retinal glial cells with collagen matrices: implications for pathogenesis of cell-mediated vitreous traction.
de Juan E; Dickson J; Hatchell DL
Graefes Arch Clin Exp Ophthalmol; 1989; 227(5):494-8. PubMed ID: 2806936
[TBL] [Abstract][Full Text] [Related]
16. [The role of the vitreous body in diseases of neighboring structures].
Gekeler K; Priglinger S; Gekeler F; Priglinger C
Ophthalmologe; 2015 Jul; 112(7):564-71. PubMed ID: 26142226
[TBL] [Abstract][Full Text] [Related]
17. Effects of TGF-beta and TGF-beta neutralizing antibodies on fibroblast-induced collagen gel contraction: implications for proliferative vitreoretinopathy.
Pena RA; Jerdan JA; Glaser BM
Invest Ophthalmol Vis Sci; 1994 May; 35(6):2804-8. PubMed ID: 8188474
[TBL] [Abstract][Full Text] [Related]
18. [Anatomic physiological features of vitreoretinal changes].
Krivosheina OI; Zapuskalov IV
Vestn Oftalmol; 2009; 125(2):50-3. PubMed ID: 19517835
[No Abstract] [Full Text] [Related]
19. Role of TGF-beta in proliferative vitreoretinal diseases and ROCK as a therapeutic target.
Kita T; Hata Y; Arita R; Kawahara S; Miura M; Nakao S; Mochizuki Y; Enaida H; Goto Y; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17504-9. PubMed ID: 18952846
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of posterior vitreous detachment.
Akiba J; Ueno N; Chakrabarti B
Graefes Arch Clin Exp Ophthalmol; 1993 Jul; 231(7):408-12. PubMed ID: 8104849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
